Investor suitability

For those who:

• want exposure to companies that are involved in the global biotechnology and genomics industry
• are investing for the medium and/or long term
• can tolerate medium to high risk

Notes

Underlying Index Guidelines

Fund overview

The ETF seeks to replicate, to the extent reasonably possible, the performance of a global biotechnology and genomics industry index, net of expenses. Currently, the ETF seeks to replicate the performance of the Solactive Global Genomics Immunology and Medical Revolution CAD Hedged Index (the “Index”). The Index intends to track the performance of companies that have business operations in the global biotechnology and genomics industry using the ARTIS® classification system. The Index hedges foreign currency exposure back to Canadian dollars.

Fund/ETF Facts (2022-12-01)